首页 > 最新文献

Advances in Obstetrics and Gynecology Research最新文献

英文 中文
Observation on the Effect of Individualized Nutrition Combined with Exercise Therapy for Pregnant Women with Gestational Diabetes Mellitus 个体化营养联合运动治疗妊娠期糖尿病的疗效观察
Pub Date : 2023-09-25 DOI: 10.26689/aogr.v1i2.5252
Jingjing Jiang
Objective: To analyze the effect of individualized nutrition combined with exercise therapy for pregnant women with gestational diabetes mellitus. Methods: From March 2021 to March 2023, 100 pregnant women with gestational diabetes in our hospital were randomly divided into a control group and an observation group (50 cases in each group). The control group received routine nursing care, and the observation group received individualized nutrition and exercise therapy, and the intervention effects of the two groups were compared. Results: The fasting, 2-hour postprandial blood glucose, and glycosylated hemoglobin of the observation group were lower than those of the control group; the weight gain of each time period during pregnancy was lower than that of the control group; the incidence of adverse pregnancy events was lower than that of the control group; the quality-of-life score was higher than that of the control group (P < 0.05). Conclusion: Among pregnant women with gestational diabetes, individualized nutrition, and exercise therapy intervention can improve their blood sugar indicators, help control their weight during pregnancy, prevent adverse pregnancy events, and significantly improve their quality of life.
目的:分析个体化营养结合运动治疗对妊娠期糖尿病孕妇的疗效。方法:选取2021年3月~ 2023年3月我院收治的妊娠期糖尿病孕妇100例,随机分为对照组和观察组,每组各50例。对照组给予常规护理,观察组给予个体化营养和运动治疗,比较两组干预效果。结果:观察组患者空腹、餐后2 h血糖、糖化血红蛋白均低于对照组;妊娠各时期体重增加均低于对照组;妊娠不良事件发生率低于对照组;生活质量评分高于对照组(P <0.05)。结论:在妊娠期糖尿病孕妇中,个体化营养和运动治疗干预可以改善其血糖指标,帮助控制孕期体重,预防孕期不良事件,显著提高其生活质量。
{"title":"Observation on the Effect of Individualized Nutrition Combined with Exercise Therapy for Pregnant Women with Gestational Diabetes Mellitus","authors":"Jingjing Jiang","doi":"10.26689/aogr.v1i2.5252","DOIUrl":"https://doi.org/10.26689/aogr.v1i2.5252","url":null,"abstract":"Objective: To analyze the effect of individualized nutrition combined with exercise therapy for pregnant women with gestational diabetes mellitus. Methods: From March 2021 to March 2023, 100 pregnant women with gestational diabetes in our hospital were randomly divided into a control group and an observation group (50 cases in each group). The control group received routine nursing care, and the observation group received individualized nutrition and exercise therapy, and the intervention effects of the two groups were compared. Results: The fasting, 2-hour postprandial blood glucose, and glycosylated hemoglobin of the observation group were lower than those of the control group; the weight gain of each time period during pregnancy was lower than that of the control group; the incidence of adverse pregnancy events was lower than that of the control group; the quality-of-life score was higher than that of the control group (P < 0.05). Conclusion: Among pregnant women with gestational diabetes, individualized nutrition, and exercise therapy intervention can improve their blood sugar indicators, help control their weight during pregnancy, prevent adverse pregnancy events, and significantly improve their quality of life.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"128 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135817367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Progress on Pathogenesis and Treatment of Primary Dysmenorrhea 原发性痛经的发病机制及治疗研究进展
Pub Date : 2023-09-25 DOI: 10.26689/aogr.v1i2.5224
Huijie Ma, Linyan Li, Boya Zhang, Jun Chen, Shu Yuan, Guizhi Wang, Yingui Sun
Primary dysmenorrhea is one of the common gynecological diseases of women of childbearing age, which can affect the work, study, and life of patients in severe cases. From the perspective of Western medicine, primary dysmenorrhea is caused by excessive secretion of prostaglandin and contraction of uterine smooth muscle, so the treatment focus of Western medicine is oral non-steroidal anti-inflammatory drugs or contraceptives, but its side effects cannot be ignored. From the perspective of Chinese medicine, primary dysmenorrhea is caused by qi-blood stagnation, so the focus of Chinese medication is dialectical treatment, which can improve qi-blood stagnation by acupuncture, decoction, moxibustion, etc., with fewer side effects and long-term clinical significance. The purpose of this paper is to analyze the relevant literature about the pathogenesis and treatment of primary dysmenorrhea in recent years, and to understand the research progress of primary dysmenorrhea in Western medicine and traditional Chinese medicine, so as to provide a reference for clinical treatment of primary dysmenorrhea.
原发性痛经是育龄妇女常见的妇科疾病之一,严重者可影响患者的工作、学习和生活。从西医的角度来看,原发性痛经是由前列腺素分泌过多和子宫平滑肌收缩引起的,因此西医的治疗重点是口服非甾体类抗炎药或避孕药,但其副作用不容忽视。从中医的角度来看,原发性痛经是气血郁结引起的,所以中医的重点是辨证论治,可以通过针灸、汤剂、艾灸等方法改善气血郁结,副作用少,临床意义长远。本文旨在分析近年来有关原发性痛经发病机制及治疗的相关文献,了解西医与中医对原发性痛经的研究进展,为临床治疗原发性痛经提供参考。
{"title":"Research Progress on Pathogenesis and Treatment of Primary Dysmenorrhea","authors":"Huijie Ma, Linyan Li, Boya Zhang, Jun Chen, Shu Yuan, Guizhi Wang, Yingui Sun","doi":"10.26689/aogr.v1i2.5224","DOIUrl":"https://doi.org/10.26689/aogr.v1i2.5224","url":null,"abstract":"Primary dysmenorrhea is one of the common gynecological diseases of women of childbearing age, which can affect the work, study, and life of patients in severe cases. From the perspective of Western medicine, primary dysmenorrhea is caused by excessive secretion of prostaglandin and contraction of uterine smooth muscle, so the treatment focus of Western medicine is oral non-steroidal anti-inflammatory drugs or contraceptives, but its side effects cannot be ignored. From the perspective of Chinese medicine, primary dysmenorrhea is caused by qi-blood stagnation, so the focus of Chinese medication is dialectical treatment, which can improve qi-blood stagnation by acupuncture, decoction, moxibustion, etc., with fewer side effects and long-term clinical significance. The purpose of this paper is to analyze the relevant literature about the pathogenesis and treatment of primary dysmenorrhea in recent years, and to understand the research progress of primary dysmenorrhea in Western medicine and traditional Chinese medicine, so as to provide a reference for clinical treatment of primary dysmenorrhea.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135817368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Application of Multimodal Analgesia Based on the ERAS Concept in Patients Undergoing Laparoscopic Surgery for Gynecological Tumors 基于ERAS概念的多模式镇痛在妇科肿瘤腹腔镜手术中的应用
Pub Date : 2023-09-25 DOI: 10.26689/aogr.v1i2.5170
Jun Peng, Xiang Shen, Yanfang Deng, Xinghui Yang, Yuezhimu Buwu
Objective: The application effect of multimodal analgesia based on the enhanced recovery after surgery (ERAS)concept in patients undergoing laparoscopic surgery for gynecological tumors. Methods: 48 patients with laparoscopic surgery for gynecological tumors were included, selected from January to December 2022, and randomly divided into the control group and observation group, with 24 cases in each group, to compare the effects. Results: The pain scores at each time point in the observation group were lower than those in the control group, and the recovery time of analgesic gas and out-of-bed activity, and postoperative length of stay were shorter than those in the control group (P < 0.05). Conclusion: Laparoscopic technology brings benefits to patients with gynecological tumors, realizes minimally invasive treatment, and reduces damage, but postoperative pain is still a key factor affecting prognosis. Multimodal analgesia based on the concept of ERAS can play a significant role in relieving pain, which has an important impact on improving the physical and mental state of patients and accelerating postoperative recovery.
目的:探讨基于ERAS (enhanced recovery after surgery)理念的多模式镇痛在妇科肿瘤腹腔镜手术中的应用效果。方法:选取2022年1月~ 12月腹腔镜妇科肿瘤手术患者48例,随机分为对照组和观察组,每组24例,比较效果。结果:观察组患者各时间点疼痛评分均低于对照组,镇痛气体、下床活动恢复时间、术后住院时间均短于对照组(P <0.05)。结论:腹腔镜技术给妇科肿瘤患者带来益处,实现了微创治疗,减少了损伤,但术后疼痛仍是影响预后的关键因素。基于ERAS理念的多模态镇痛可以起到明显的镇痛作用,对改善患者身心状态,加快术后恢复有重要影响。
{"title":"Application of Multimodal Analgesia Based on the ERAS Concept in Patients Undergoing Laparoscopic Surgery for Gynecological Tumors","authors":"Jun Peng, Xiang Shen, Yanfang Deng, Xinghui Yang, Yuezhimu Buwu","doi":"10.26689/aogr.v1i2.5170","DOIUrl":"https://doi.org/10.26689/aogr.v1i2.5170","url":null,"abstract":"Objective: The application effect of multimodal analgesia based on the enhanced recovery after surgery (ERAS)concept in patients undergoing laparoscopic surgery for gynecological tumors. Methods: 48 patients with laparoscopic surgery for gynecological tumors were included, selected from January to December 2022, and randomly divided into the control group and observation group, with 24 cases in each group, to compare the effects. Results: The pain scores at each time point in the observation group were lower than those in the control group, and the recovery time of analgesic gas and out-of-bed activity, and postoperative length of stay were shorter than those in the control group (P < 0.05). Conclusion: Laparoscopic technology brings benefits to patients with gynecological tumors, realizes minimally invasive treatment, and reduces damage, but postoperative pain is still a key factor affecting prognosis. Multimodal analgesia based on the concept of ERAS can play a significant role in relieving pain, which has an important impact on improving the physical and mental state of patients and accelerating postoperative recovery.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135816676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the Clinical Application Value of Colposcopy Biopsy in the Screening of Cervical Precancerous Lesions 阴道镜活检在宫颈癌前病变筛查中的临床应用价值分析
Pub Date : 2023-09-25 DOI: 10.26689/aogr.v1i2.5180
Yan Wang, Mindan Xu
Objective: To analyze the value of colposcopy biopsy in the screening of cervical precancerous lesions. Methods: 5,000 patients with suspected cervical precancerous lesions were used as samples. From January 2020 to December 2022, pathological examination and colposcopy biopsy were carried out, and the value of colposcopy biopsy was analyzed. Results: 1,503 cases were positive and 3,497 cases were negative by pathology, whereas 1,432 cases were positive and 3,568 cases were negative by colposcopy biopsy. The diagnostic sensitivity, specificity, and accuracy of colposcopy biopsy were 99.69%, 94.54%, and 97.78%, respectively. Cervicitis, CIN Ⅰ grade, CIN Ⅱ grade, CIN Ⅲ grade, and cervical cancer had no statistical difference with the pathological examination (P > 0.05). Conclusion: The colposcopy biopsy scheme is used in the screening of cervical precancerous lesions, the detection accuracy is high in consistency with the pathological results, the risk of missed diagnosis and misdiagnosis is low, and it is efficient and feasible.
目的:分析阴道镜活检在宫颈癌前病变筛查中的价值。方法:以5000例疑似宫颈癌前病变患者为样本。2020年1月至2022年12月进行病理检查和阴道镜活检,分析阴道镜活检的价值。结果:病理检查阳性1503例,阴性3497例;阴道镜活检阳性1432例,阴性3568例。阴道镜活检诊断的敏感性为99.69%,特异性为94.54%,准确性为97.78%。宫颈炎、CINⅠ分级、CINⅡ分级、CINⅢ分级、宫颈癌与病理检查比较无统计学差异(P >0.05)。结论:阴道镜活检方案用于宫颈癌前病变筛查,检测准确率与病理结果一致性高,漏诊、误诊风险低,高效可行。
{"title":"Analysis of the Clinical Application Value of Colposcopy Biopsy in the Screening of Cervical Precancerous Lesions","authors":"Yan Wang, Mindan Xu","doi":"10.26689/aogr.v1i2.5180","DOIUrl":"https://doi.org/10.26689/aogr.v1i2.5180","url":null,"abstract":"Objective: To analyze the value of colposcopy biopsy in the screening of cervical precancerous lesions. Methods: 5,000 patients with suspected cervical precancerous lesions were used as samples. From January 2020 to December 2022, pathological examination and colposcopy biopsy were carried out, and the value of colposcopy biopsy was analyzed. Results: 1,503 cases were positive and 3,497 cases were negative by pathology, whereas 1,432 cases were positive and 3,568 cases were negative by colposcopy biopsy. The diagnostic sensitivity, specificity, and accuracy of colposcopy biopsy were 99.69%, 94.54%, and 97.78%, respectively. Cervicitis, CIN Ⅰ grade, CIN Ⅱ grade, CIN Ⅲ grade, and cervical cancer had no statistical difference with the pathological examination (P &gt; 0.05). Conclusion: The colposcopy biopsy scheme is used in the screening of cervical precancerous lesions, the detection accuracy is high in consistency with the pathological results, the risk of missed diagnosis and misdiagnosis is low, and it is efficient and feasible.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135817189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Vitamin E Supplemented with Calcium in the Treatment of Hypertension During Pregnancy on Maternal and Infant Outcomes 维生素E加钙治疗妊娠期高血压对母婴结局的影响
Pub Date : 2023-09-21 DOI: 10.26689/aogr.v1i2.5213
Yanjun Li
Objective: To investigate the effect of vitamin E supplemented with calcium in the treatment of hypertension during pregnancy on maternal and infant outcomes. Methods: 60 patients with gestational hypertension admitted from January 2020 to December 2022 were recruited and randomly divided into the control group and the observation group, each group including 30 patients. The control group was given routine treatment, whereas the observation group was given routine treatment combined with vitamin E-supplemented calcium therapy, and both groups received treatment until delivery. The clinical effects of the observation group and the control group after treatment, systolic and diastolic blood pressure, mean arterial pressure, urine protein, blood lipid levels at different time points (before and after treatment), and maternal and child outcomes during treatment were uniformly compared and analyzed. Results: After treatment, the total clinical effective rate (93.33%) of the observation group was significantly higher than that of the control group (70.00%); compared with before treatment, the systolic blood pressure, diastolic blood pressure, mean arterial pressure, urine protein, TC, and TG levels of the two groups were all lower after treatment, and the observation group was at a lower level; there was no significant difference in the incidence of hemorrhage (P > 0.05). Conclusion: Vitamin E supplemented with calcium has a significant effect on the treatment of hypertension during pregnancy, which can help reduce blood pressure and blood lipid levels, reduce urinary protein content, improve maternal and child outcomes, and improve safety.
目的:探讨维生素E加钙治疗妊娠期高血压对母婴结局的影响。方法:选取2020年1月~ 2022年12月收治的妊娠期高血压患者60例,随机分为对照组和观察组,每组各30例。对照组给予常规治疗,观察组给予常规治疗联合维生素e补钙治疗,两组均治疗至分娩。对观察组和对照组患儿治疗后的临床疗效、不同时间点(治疗前后)收缩压、舒张压、平均动脉压、尿蛋白、血脂水平及治疗期间母婴结局进行统一比较分析。结果:治疗后,观察组临床总有效率(93.33%)显著高于对照组(70.00%);与治疗前比较,两组患者治疗后收缩压、舒张压、平均动脉压、尿蛋白、TC、TG水平均降低,且观察组较低;两组出血发生率无显著差异(P >0.05)。结论:维生素E加钙对妊娠期高血压的治疗效果显著,有助于降低血压和血脂水平,降低尿蛋白含量,改善母婴结局,提高安全性。
{"title":"Effect of Vitamin E Supplemented with Calcium in the Treatment of Hypertension During Pregnancy on Maternal and Infant Outcomes","authors":"Yanjun Li","doi":"10.26689/aogr.v1i2.5213","DOIUrl":"https://doi.org/10.26689/aogr.v1i2.5213","url":null,"abstract":"Objective: To investigate the effect of vitamin E supplemented with calcium in the treatment of hypertension during pregnancy on maternal and infant outcomes. Methods: 60 patients with gestational hypertension admitted from January 2020 to December 2022 were recruited and randomly divided into the control group and the observation group, each group including 30 patients. The control group was given routine treatment, whereas the observation group was given routine treatment combined with vitamin E-supplemented calcium therapy, and both groups received treatment until delivery. The clinical effects of the observation group and the control group after treatment, systolic and diastolic blood pressure, mean arterial pressure, urine protein, blood lipid levels at different time points (before and after treatment), and maternal and child outcomes during treatment were uniformly compared and analyzed. Results: After treatment, the total clinical effective rate (93.33%) of the observation group was significantly higher than that of the control group (70.00%); compared with before treatment, the systolic blood pressure, diastolic blood pressure, mean arterial pressure, urine protein, TC, and TG levels of the two groups were all lower after treatment, and the observation group was at a lower level; there was no significant difference in the incidence of hemorrhage (P &gt; 0.05). Conclusion: Vitamin E supplemented with calcium has a significant effect on the treatment of hypertension during pregnancy, which can help reduce blood pressure and blood lipid levels, reduce urinary protein content, improve maternal and child outcomes, and improve safety.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136238931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Clinical Study of Low Molecular Weight Heparin Sodium Injection Combined with Magnesium Sulfate Injection and Labetalol Tablets in the Treatment of Severe Pregnancy-Induced Hypertension 低分子肝素钠注射液联合硫酸镁注射液、拉贝他洛尔片治疗重度妊高征的临床研究
Pub Date : 2023-06-26 DOI: 10.26689/aogr.v1i1.5058
Hongyou Chen, Lihua Song, Fei Wang, Yan Gao, Shuang Zhang
Objective: To investigate the clinical effect of low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension. Methods: A total of 48 patients with severe pregnancy-induced hypertension admitted from February 2021 to February 2023 were selected, and the patients were divided into two groups by simple sampling, with 24 cases in each group. Patients in the control group received labetalol orally and intravenous infusion of magnesium sulfate, whereas those in the observation group received subcutaneous injection of low molecular weight heparin sodium on the basis of the control group. The two groups of patients underwent 5 days of treatment, and the blood pressure control, vascular endothelial function, renal function, and blood coagulation were compared between the two groups. Results: Before treatment, there were no significant differences in blood pressure readings, endothelin-1 (ET-1) and nitric oxide (NO) levels, serum creatinine (SCr) and blood urea nitrogen (BUN) levels, and the four coagulation indices between the two groups (all P > 0.05). After treatment, the blood pressure readings in the observation group were lower than those in the control group (P < 0.05); ET-1 in the observation group was lower than that in the control group, and the NO level in the observation group was higher than that in the control group (P < 0.05); compared with the control group, the observation group had lower SCr and BUN (P < 0.05), longer prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT), and lower fibrinogen (Fib) level (P < 0.05). Conclusion: Low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension can help control blood pressure levels, promote the recovery of vascular endothelial function and renal function, and effectively correct coagulation function.
目的:探讨低分子肝素钠注射液联合硫酸镁注射液、拉贝他洛尔治疗重度妊高征的临床疗效。方法:选择2021年2月~ 2023年2月收治的重症妊高征患者48例,采用简单抽样法分为两组,每组24例。对照组患者口服拉贝他洛尔并静脉滴注硫酸镁,观察组患者在对照组的基础上皮下注射低分子肝素钠。两组患者均治疗5 d,比较两组患者血压控制、血管内皮功能、肾功能、凝血情况。结果:治疗前,两组患者血压、内皮素-1 (ET-1)、一氧化氮(no)水平、血清肌酐(SCr)、尿素氮(BUN)水平及凝血四项指标比较,差异均无统计学意义(P > 0.05)。治疗后,观察组患者血压读数低于对照组(P < 0.05);观察组患者ET-1水平低于对照组,NO水平高于对照组(P < 0.05);观察组患者SCr、BUN低于对照组(P < 0.05),凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)延长,纤维蛋白原(Fib)水平低于对照组(P < 0.05)。结论:低分子肝素钠注射液联合硫酸镁注射液、拉贝他洛尔治疗重度妊高增高,有助于控制血压水平,促进血管内皮功能和肾功能恢复,有效纠正凝血功能。
{"title":"A Clinical Study of Low Molecular Weight Heparin Sodium Injection Combined with Magnesium Sulfate Injection and Labetalol Tablets in the Treatment of Severe Pregnancy-Induced Hypertension","authors":"Hongyou Chen, Lihua Song, Fei Wang, Yan Gao, Shuang Zhang","doi":"10.26689/aogr.v1i1.5058","DOIUrl":"https://doi.org/10.26689/aogr.v1i1.5058","url":null,"abstract":"Objective: To investigate the clinical effect of low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension. Methods: A total of 48 patients with severe pregnancy-induced hypertension admitted from February 2021 to February 2023 were selected, and the patients were divided into two groups by simple sampling, with 24 cases in each group. Patients in the control group received labetalol orally and intravenous infusion of magnesium sulfate, whereas those in the observation group received subcutaneous injection of low molecular weight heparin sodium on the basis of the control group. The two groups of patients underwent 5 days of treatment, and the blood pressure control, vascular endothelial function, renal function, and blood coagulation were compared between the two groups. Results: Before treatment, there were no significant differences in blood pressure readings, endothelin-1 (ET-1) and nitric oxide (NO) levels, serum creatinine (SCr) and blood urea nitrogen (BUN) levels, and the four coagulation indices between the two groups (all P > 0.05). After treatment, the blood pressure readings in the observation group were lower than those in the control group (P < 0.05); ET-1 in the observation group was lower than that in the control group, and the NO level in the observation group was higher than that in the control group (P < 0.05); compared with the control group, the observation group had lower SCr and BUN (P < 0.05), longer prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT), and lower fibrinogen (Fib) level (P < 0.05). Conclusion: Low molecular weight heparin sodium injection combined with magnesium sulfate injection and labetalol in the treatment of severe pregnancy-induced hypertension can help control blood pressure levels, promote the recovery of vascular endothelial function and renal function, and effectively correct coagulation function.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117081208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Buzhong Yiqi Decoction (Middle Qi Tonifying Decoction) in the Treatment of Chronic Cervicitis of Spleen Deficiency Type 补中益气汤治疗脾虚型慢性宫颈炎的疗效观察
Pub Date : 2023-06-26 DOI: 10.26689/aogr.v1i1.5066
Fajuan Tian, Qihong Fan
Objective: To observe the effects of modified Buzhong Yiqi Decoction (Middle Qi Tonifying Decoction) in the treatment of chronic cervicitis of spleen deficiency type. Methods: From May 2021 to December 2022, 80 patients from our hospital (The First People’s Hospital of Huangzhong District) were randomly divided into two groups (40 cases/group). Patients in the control group were treated with Western medicine, whereas patients in the observation group were treated with Buzhong Yiqi Decoction (Middle Qi Tonifying Decoction) on the basis of Western medicine. The effects (curative effect, traditional Chinese medicine [TCM] symptom scores, and incidence of adverse reactions) were compared between both groups. Results: Before treatment, the differences in TCM symptom scores and incidence of adverse reactions between the two groups were not statistically significant (P > 0.05). Compared with the control group, the observation group had significantly lower TCM symptom scores after treatment and higher curative effect (P < 0.05). Conclusion: For patients with chronic cervicitis of spleen deficiency type, Buzhong Yiqi Decoction (Middle Qi Tonifying Decoction) is effective. Significant improvement in symptoms is evident with the use of Buzhong Yiqi Decoction, and it has little side effects. Given its outstanding therapeutic advantages, its application should be advocated in clinical practice.
目的:观察补中益气汤加减治疗脾虚型慢性宫颈炎的疗效。方法:选取我院(黄中区第一人民医院)于2021年5月至2022年12月收治的80例患者,随机分为两组(40例/组)。对照组采用西药治疗,观察组在西药基础上加用补中益气汤治疗。比较两组疗效(疗效、中医症状评分、不良反应发生率)。结果:治疗前,两组患者中医症状评分及不良反应发生率比较,差异均无统计学意义(P > 0.05)。观察组治疗后中医症状评分明显低于对照组,疗效显著高于对照组(P < 0.05)。结论:补中益气汤治疗脾虚型慢性宫颈炎疗效确切。补中益气汤治疗后症状明显改善,且副作用小。鉴于其突出的治疗优势,应在临床实践中提倡应用。
{"title":"Effects of Buzhong Yiqi Decoction (Middle Qi Tonifying Decoction) in the Treatment of Chronic Cervicitis of Spleen Deficiency Type","authors":"Fajuan Tian, Qihong Fan","doi":"10.26689/aogr.v1i1.5066","DOIUrl":"https://doi.org/10.26689/aogr.v1i1.5066","url":null,"abstract":"Objective: To observe the effects of modified Buzhong Yiqi Decoction (Middle Qi Tonifying Decoction) in the treatment of chronic cervicitis of spleen deficiency type. Methods: From May 2021 to December 2022, 80 patients from our hospital (The First People’s Hospital of Huangzhong District) were randomly divided into two groups (40 cases/group). Patients in the control group were treated with Western medicine, whereas patients in the observation group were treated with Buzhong Yiqi Decoction (Middle Qi Tonifying Decoction) on the basis of Western medicine. The effects (curative effect, traditional Chinese medicine [TCM] symptom scores, and incidence of adverse reactions) were compared between both groups. Results: Before treatment, the differences in TCM symptom scores and incidence of adverse reactions between the two groups were not statistically significant (P > 0.05). Compared with the control group, the observation group had significantly lower TCM symptom scores after treatment and higher curative effect (P < 0.05). Conclusion: For patients with chronic cervicitis of spleen deficiency type, Buzhong Yiqi Decoction (Middle Qi Tonifying Decoction) is effective. Significant improvement in symptoms is evident with the use of Buzhong Yiqi Decoction, and it has little side effects. Given its outstanding therapeutic advantages, its application should be advocated in clinical practice.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130123601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the Influence of Nifedipine + Magnesium Sulfate Therapy on the Clinical Effect of Pregnancy-Induced Hypertension, Renal Function, and Pregnancy Outcome 硝苯地平+硫酸镁治疗对妊高征临床疗效、肾功能及妊娠结局的影响分析
Pub Date : 2023-06-26 DOI: 10.26689/aogr.v1i1.5059
Yaqin Yang, Liping Zhao
Objective: To investigate the effect of nifedipine + magnesium sulfate treatment on pregnancy-induced hypertension. Methods: From January 2020 to January 2023, 60 patients with pregnancy-induced hypertension in our hospital were randomly divided into the control group and the observation group (30 cases in each group). The control group was treated with magnesium sulfate, while the observation group was treated with nifedipine and magnesium sulfate, and the clinical efficacy of the two groups was compared. The effective rate of treatment, blood pressure indicators, renal function indicators, adverse pregnancy outcomes, and quality-of-life scores were investigated. Results: The effective rate of treatment and quality-of-life score in the observation group were higher than those in the control group (P < 0.05). On the other hand, the diastolic and systolic blood pressure, the 24 h urine creatinine and albumin, as well as the adverse pregnancy outcomes were found to be lower in the observation group as compared to the control group (P < 0.05). Conclusion: For patients with pregnancy-induced hypertension, treatment with nifedipine and magnesium sulfate can achieve significant curative and remarkable effects. While improving blood pressure, it can also improve renal function, optimize pregnancy outcomes, and improve quality of life.
目的:探讨硝苯地平+硫酸镁治疗妊高征的疗效。方法:选取2020年1月~ 2023年1月我院收治的妊娠高血压患者60例,随机分为对照组和观察组,每组各30例。对照组采用硫酸镁治疗,观察组采用硝苯地平加硫酸镁治疗,比较两组临床疗效。观察治疗有效率、血压指标、肾功能指标、妊娠不良结局及生活质量评分。结果:观察组治疗有效率、生活质量评分均高于对照组(P < 0.05)。另一方面,观察组患者舒张压、收缩压、24 h尿肌酐、白蛋白及不良妊娠结局均低于对照组(P < 0.05)。结论:硝苯地平联合硫酸镁治疗妊高征患者疗效显著,效果显著。在改善血压的同时,还能改善肾功能,优化妊娠结局,提高生活质量。
{"title":"Analysis of the Influence of Nifedipine + Magnesium Sulfate Therapy on the Clinical Effect of Pregnancy-Induced Hypertension, Renal Function, and Pregnancy Outcome","authors":"Yaqin Yang, Liping Zhao","doi":"10.26689/aogr.v1i1.5059","DOIUrl":"https://doi.org/10.26689/aogr.v1i1.5059","url":null,"abstract":"Objective: To investigate the effect of nifedipine + magnesium sulfate treatment on pregnancy-induced hypertension. Methods: From January 2020 to January 2023, 60 patients with pregnancy-induced hypertension in our hospital were randomly divided into the control group and the observation group (30 cases in each group). The control group was treated with magnesium sulfate, while the observation group was treated with nifedipine and magnesium sulfate, and the clinical efficacy of the two groups was compared. The effective rate of treatment, blood pressure indicators, renal function indicators, adverse pregnancy outcomes, and quality-of-life scores were investigated. Results: The effective rate of treatment and quality-of-life score in the observation group were higher than those in the control group (P < 0.05). On the other hand, the diastolic and systolic blood pressure, the 24 h urine creatinine and albumin, as well as the adverse pregnancy outcomes were found to be lower in the observation group as compared to the control group (P < 0.05). Conclusion: For patients with pregnancy-induced hypertension, treatment with nifedipine and magnesium sulfate can achieve significant curative and remarkable effects. While improving blood pressure, it can also improve renal function, optimize pregnancy outcomes, and improve quality of life.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134440830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Observation on the Application Effect of Bedside Nursing Mode of Mother-Infant Rooming-in High-Quality Obstetric Care 母婴分房床边护理模式在高质量产科护理中的应用效果观察
Pub Date : 2023-06-26 DOI: 10.26689/aogr.v1i1.5063
Nana Li, Jian-ping Fan
Objective: To observe the application effect of bedside nursing mode of mother-infant rooming-in in high-quality obstetric care. Methods: Selected mothers (60 cases) from our hospital (January 2022–December 2022) were recruited and randomly divided into two groups (30 cases/group). The effects were compared between the routine nursing mode (control group) and the bedside nursing mode of mother-infant rooming-in (observation group). Results: Compared with the control group, the observation group scored higher in health education knowledge, and the total satisfaction was higher than that of the control group (P < 0.05). Conclusion: The bedside nursing mode of mother-infant rooming-in can improve mothers’ parenting skills and lay a foundation for post-discharge parenting. This nursing mode is novel and effective and has significant advantages in reducing anxiety while protecting mothers and babies.
目的:观察母婴分房床边护理模式在高质量产科护理中的应用效果。方法:选取我院(2022年1月~ 2022年12月)的产妇60例,随机分为两组(30例/组)。比较常规护理模式(对照组)与母婴同房床边护理模式(观察组)的效果。结果:观察组患者健康教育知识得分高于对照组,总满意度高于对照组(P < 0.05)。结论:母婴同房床边护理模式可提高母亲的育儿技能,为出院后育儿奠定基础。这种护理模式新颖有效,在减少焦虑的同时保护母婴有显著优势。
{"title":"Observation on the Application Effect of Bedside Nursing Mode of Mother-Infant Rooming-in High-Quality Obstetric Care","authors":"Nana Li, Jian-ping Fan","doi":"10.26689/aogr.v1i1.5063","DOIUrl":"https://doi.org/10.26689/aogr.v1i1.5063","url":null,"abstract":"Objective: To observe the application effect of bedside nursing mode of mother-infant rooming-in in high-quality obstetric care. Methods: Selected mothers (60 cases) from our hospital (January 2022–December 2022) were recruited and randomly divided into two groups (30 cases/group). The effects were compared between the routine nursing mode (control group) and the bedside nursing mode of mother-infant rooming-in (observation group). Results: Compared with the control group, the observation group scored higher in health education knowledge, and the total satisfaction was higher than that of the control group (P < 0.05). Conclusion: The bedside nursing mode of mother-infant rooming-in can improve mothers’ parenting skills and lay a foundation for post-discharge parenting. This nursing mode is novel and effective and has significant advantages in reducing anxiety while protecting mothers and babies.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116805221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curative Effect and Complication Rate of Abdominal Myomectomy and Laparoscopic Myomectomy in the Treatment of Uterine Fibroids 腹部子宫肌瘤切除术与腹腔镜子宫肌瘤切除术治疗子宫肌瘤的疗效及并发症发生率
Pub Date : 2023-06-23 DOI: 10.26689/aogr.v1i1.5062
Shuihua Li
Objective: To compare and analyze the clinical efficacy and complication rate of abdominal myomectomy with those of laparoscopic myomectomy in uterine fibroids. Methods: This study was carried out from January 2021 to January 2023 on 150 patients with uterine fibroids. The patients were divided into two groups, a study group (n = 75) and a control group (n = 75), by digital table grouping. Patients in the control group underwent abdominal myomectomy, whereas patients in the study group underwent laparoscopic myomectomy. Surgery-related indicators, incidence of complications, ovarian function indicators, recurrence rate, and pregnancy rate were compared between the two groups. Results: The surgery-related indicators of the study group were lower than those of the control group (P < 0.05 ); the incidence of postoperative complications was lower in the study group than in the control group (P < 0.05); the postoperative ovarian function indicators of the study group were lower than those of the control group (P < 0.05); there were no significant differences in postoperative recurrence rate and pregnancy rate between the two groups (P > 0.05). Conclusion: For patients with uterine fibroids, abdominal myomectomy and laparoscopic myomectomy have similar recurrence and pregnancy rates, but laparoscopic myomectomy can shorten the recovery time and reduce the incidence of complications and the impact on ovarian function. Therefore, the latter should be applied in clinical settings.
目的:比较分析腹部子宫肌瘤切除术与腹腔镜子宫肌瘤切除术治疗子宫肌瘤的临床疗效及并发症发生率。方法:本研究于2021年1月至2023年1月对150例子宫肌瘤患者进行研究。采用数字表分组法将患者分为研究组(n = 75)和对照组(n = 75)。对照组患者行腹部子宫肌瘤切除术,而研究组患者行腹腔镜子宫肌瘤切除术。比较两组手术相关指标、并发症发生率、卵巢功能指标、复发率、妊娠率。结果:研究组手术相关指标低于对照组(P < 0.05);研究组术后并发症发生率低于对照组(P < 0.05);研究组术后卵巢功能指标低于对照组(P < 0.05);两组术后复发率、妊娠率比较,差异均无统计学意义(P > 0.05)。结论:对于子宫肌瘤患者,腹部子宫肌瘤切除术与腹腔镜子宫肌瘤切除术的复发率和妊娠率相似,但腹腔镜子宫肌瘤切除术可缩短恢复时间,减少并发症的发生及对卵巢功能的影响。因此,后者应应用于临床设置。
{"title":"Curative Effect and Complication Rate of Abdominal Myomectomy and Laparoscopic Myomectomy in the Treatment of Uterine Fibroids","authors":"Shuihua Li","doi":"10.26689/aogr.v1i1.5062","DOIUrl":"https://doi.org/10.26689/aogr.v1i1.5062","url":null,"abstract":"Objective: To compare and analyze the clinical efficacy and complication rate of abdominal myomectomy with those of laparoscopic myomectomy in uterine fibroids. Methods: This study was carried out from January 2021 to January 2023 on 150 patients with uterine fibroids. The patients were divided into two groups, a study group (n = 75) and a control group (n = 75), by digital table grouping. Patients in the control group underwent abdominal myomectomy, whereas patients in the study group underwent laparoscopic myomectomy. Surgery-related indicators, incidence of complications, ovarian function indicators, recurrence rate, and pregnancy rate were compared between the two groups. Results: The surgery-related indicators of the study group were lower than those of the control group (P < 0.05 ); the incidence of postoperative complications was lower in the study group than in the control group (P < 0.05); the postoperative ovarian function indicators of the study group were lower than those of the control group (P < 0.05); there were no significant differences in postoperative recurrence rate and pregnancy rate between the two groups (P > 0.05). Conclusion: For patients with uterine fibroids, abdominal myomectomy and laparoscopic myomectomy have similar recurrence and pregnancy rates, but laparoscopic myomectomy can shorten the recovery time and reduce the incidence of complications and the impact on ovarian function. Therefore, the latter should be applied in clinical settings.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"126 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130558447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advances in Obstetrics and Gynecology Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1